Preparation and characterization of bioactive mesoporous wollastonite - Polycaprolactone composite scaffold.
about
In vitro characterizations of mesoporous hydroxyapatite as a controlled release delivery device for VEGF in orthopedic applications.Mechanical and in vitro biological performance of graphene nanoplatelets reinforced calcium silicate compositeWollastonite nanofiber-doped self-setting calcium phosphate bioactive cement for bone tissue regeneration.Engineering dextran-based scaffolds for drug delivery and tissue repair.Preparation and characterization of multifunctional magnetic mesoporous calcium silicate materials.Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review.Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application.Review and the state of the art: Sol-gel and melt quenched bioactive glasses for tissue engineering.Calcium silicate-based drug delivery systems.Biomaterial-Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives.Amorphous calcium silicate hydrate/block copolymer hybrid nanoparticles: synthesis and application as drug carriers.Antibacterial hemostatic dressings with nanoporous bioglass containing silver.Composite scaffolds of mesoporous bioactive glass and polyamide for bone repair.Poly(ε-caprolactone)/nano fluoridated hydroxyapatite scaffolds for bone tissue engineering: in vitro degradation and biocompatibility study.Preparation of luminescent and mesoporous Eu3+/Tb3+ doped calcium silicate microspheres as drug carriers via a template route.Crystal structures of CaSiO3 polymorphs control growth and osteogenic differentiation of human mesenchymal stem cells on bioceramic surfacesThe In Vitro Bioactivity, Degradation, and Cytotoxicity of Polymer-Derived Wollastonite-Diopside Glass-Ceramics.Ultrathin calcium silicate hydrate nanosheets with large specific surface areas: synthesis, crystallization, layered self-assembly and applications as excellent adsorbents for drug, protein, and metal ions.Drug-nanocarrier interaction--tracking the local structure of calcium silicate upon ibuprofen loading with X-ray absorption near edge structure (XANES).Bioactivity and Cell Compatibility of β-Wollastonite Derived from Rice Husk Ash and Limestone.Influences of mesoporous magnesium calcium silicate on mineralization, degradability, cell responses, curcumin release from macro-mesoporous scaffolds of gliadin based biocomposites.Does the tissue engineering architecture of poly(3-hydroxybutyrate) scaffold affects cell-material interactions?
P2860
Q34349168-C030C250-4C69-4C00-8014-035A090E2855Q35258088-C60ABDB8-9377-401E-BB06-B94B81BA4501Q36119551-F29642F7-752B-473B-B2AA-821929687523Q36205757-D4095C80-AED8-49D8-90BC-8C311225D4F1Q37386439-7FED6983-43E4-4872-B3CD-15C8C2C5337BQ37987823-DF2EFC5B-19E7-4394-AF5B-256A065BA767Q38112427-DF046B88-03DE-49DC-95D1-B367605AB210Q38523506-73B34FDA-DEE6-447C-B8B7-39573A25C3C9Q38840121-515CF61C-433E-465C-B51E-B9B57EA3ECF9Q38912627-4279BC8A-38C2-40BD-BEC3-15E5803D6671Q39178323-079F69BA-82FE-44AB-B9FB-86E4870CE1AFQ39322950-579E16D4-4911-4D3D-BEF9-57377370A4ABQ39334843-9A0F37BF-EBBB-407C-88D1-BAF9C2D78568Q39424223-7C347B85-C5D2-4FE4-9069-7562F14177AAQ39616110-4FE929B3-D875-45A4-8FEB-0E3AF8402881Q40342188-0A5C4A9F-C328-47E0-8F90-8534359338DFQ40992330-3A4B995C-7476-45D4-A4A2-F57326C115D5Q43357566-B4FD9862-EB1C-4CE5-B110-F6C7CDC2240DQ44209627-402F6439-E6CE-4F32-B6D5-0D00CEA15C29Q44673195-A4040DAF-38E8-4010-B169-246D98361B39Q47723958-5227EEF6-4127-4AF2-83C8-8C5682B9975DQ57813495-BF6FF11D-7080-4CA2-B613-76D95B24E280
P2860
Preparation and characterization of bioactive mesoporous wollastonite - Polycaprolactone composite scaffold.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Preparation and characterizati ...... prolactone composite scaffold.
@en
Preparation and characterizati ...... prolactone composite scaffold.
@nl
type
label
Preparation and characterizati ...... prolactone composite scaffold.
@en
Preparation and characterizati ...... prolactone composite scaffold.
@nl
prefLabel
Preparation and characterizati ...... prolactone composite scaffold.
@en
Preparation and characterizati ...... prolactone composite scaffold.
@nl
P2093
P1433
P1476
Preparation and characterizati ...... prolactone composite scaffold.
@en
P2093
Changsheng Liu
Chenglong Dai
Fangping Chen
Jiancan Su
Jung-Woog Shin
P304
P356
10.1016/J.BIOMATERIALS.2008.10.046
P577
2008-11-18T00:00:00Z